Stroke recovery goes home: robot hand trainer could boost therapy without a therapist

NCT ID NCT07674238

Not yet recruiting Disease control Sponsor: Swiss Federal Institute of Technology Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether stroke survivors can safely use a robot called ReHandyBot to exercise their hand at home without a therapist present. Participants first learn how to use the device at a clinic, then take it home to train on their own. The goal is to see if unsupervised home therapy can increase the amount of hand exercise patients get, which may improve recovery while reducing the need for constant therapist supervision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ReHandyBot hand rehabilitation device
What this could lead to: If it works, this could show that unsupervised home robot therapy helps stroke survivors recover hand function with less burden on therapists and the healthcare system.
What could go wrong: This is a small exploratory study (40 people) focused on feasibility and dose, not on proving recovery. The device may be difficult to use at home, and results may not apply to all stroke patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE

Contacts and locations

Locations

Rehaklinik Bellikon

Bellikon, 5454, Switzerland
Rehaklinik Valens

Valens, 7317, Switzerland
Rehaklinik Zihlschlacht AG

Zihlschlacht, 8588, Switzerland
University Hospital, Geneva

Geneva, 1211, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.